Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer

World Journal of Gastroenterology

Volumn 16, Issue 9, 2010, Pages 1138-1149

  Wang, Zhen ^a   Chen, Jun Qiang ^a   Cao, Yun Fei ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

D2 lymphadenectomy; Gastric cancer; Meta analysis; Para aortic nodal dissection; Systematic review

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; OPERATION DURATION; OVERALL SURVIVAL; PARAAORTIC NODAL DISSECTION; PATIENT SAFETY; PERITONEUM METASTASIS; POSTOPERATIVE HEMORRHAGE; STOMACH CANCER; SURGICAL MORTALITY; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 77949472049     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i9.1138     Document Type: Article

References (52)

1. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354-362
2. Parkin DM, Whelan SL, Ferlay J. Cancer Incidence in Five Continents, vol VII. Lyon, France: International Agency for Research on Cancer, 1997: 822-823
3. Yamamoto S. Stomach cancer incidence in the world. Jpn J Clin Oncol 2001; 31: 471
4. Wang ZN, Lu C, Xu HM. Lymph node metastasis of upper gastric cancer and its significance in surgical treatment. Zhongguo Shiyong Waike Zazhi 2002; 22: 611-612
5. Tsubono Y, Hisamichi S. Screening for gastric cancer in Japan. Gastric Cancer 2000; 3: 9-18
6. Roukos DH, Kappas AM. Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2005; 2: 98-107
7. Alberts SR, Cervantes A, van de Velde CJ. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 2003; 14 Suppl 2: ii31-ii36
8. Ito Y, Ohno Y, Rachet B, Coleman MP, Tsukuma H, Oshima A. Cancer survival trends in Osaka, Japan: the influence of age and stage at diagnosis. Jpn J Clin Oncol 2007; 37: 452-458
9. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007; 8: 784-796
10. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108
11. Chen L, Zhang Y, Wei B, Zhao XY, Li T. [Surgical treatment for patients with gastric cancer: report of 2335 cases] Zhonghua Weichang Waike Zazhi 2007; 10: 421-424
12. Lewis WG, Edwards P, Barry JD, Khan S, Dhariwal D, Hodzovic I, Allison MC, Shute K. D2 or not D2? The gastrectomy question. Gastric Cancer 2002; 5: 29-34
13. Degiuli M, Sasako M, Ponzetto A, Allone T, Soldati T, Calgaro M, Balcet F, Bussone R, Olivieri F, Scaglione D, Danese F, Morino M, Calderini P, Capussotti L, Fronda G, Garavoglia M, Locatelli L, Dellepiane M, Rossini FP, Calvo F. Extended lymph node dissection for gastric cancer: results of a prospective, multi-centre analysis of morbidity and mortality in 118 consecutive cases. Eur J Surg Oncol 1997; 23: 310-314
14. Volpe CM, Driscoll DL, Miloro SM, Douglass HO Jr. Survival benefit of extended D2 resection for proximal gastric cancer. J Surg Oncol 1997; 64: 231-236
15. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Hada M, Schmidt-Matthiesen A, Dahl O. Should systematic lymph node dissection be recommended for gastric cancer?
16. Roviello F, Marrelli D, Morgagni P, de Manzoni G, Di Leo A, Vindigni C, Saragoni L, Tomezzoli A, Kurihara H. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study. Ann Surg Oncol 2002; 9: 894-900
17. Zilberstein B, da Costa Martins B, Jacob CE, Bresciani C, Lopasso FP, de Cleva R, Pinto Junior PE, Junior UR, Perez RO, Gama-Rodrigues J. Complications of gastrectomy with lymphadenectomy in gastric cancer. Gastric Cancer 2004; 7: 254-259
18. McCulloch P, Nita ME, Kazi H, Gama-Rodrigues J. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2004; CD001964
19. Nakane Y, Okamura S, Masuya Y, Okumura S, Akehira K, Hioki K. Incidence and prognosis of para-aortic lymph node metastasis in gastric cancer. Hepatogastroenterology 1998; 45: 1901-1906
20. Isozaki H, Okajima K, Fujii K, Nomura E, Izumi N, Mabuchi H, Nakamura M, Hara H. Effectiveness of paraaortic lymph node dissection for advanced gastric cancer. Hepatogastroenterology 1999; 46: 549-554
21. Takashima S, Kosaka T. Results and controversial issues regarding a para-aortic lymph node dissection for advanced gastric cancer. Surg Today 2005; 35: 425-431
22. De Manzoni G, Di Leo A, Borzellino G, Bonfiglio M, Pedrazzani C, Tasselli S, Castelli A, Zerman G, Fersini A. [Para-aortic lymph node involvement in gastric adenocarcinoma] Ann Chir 2001; 126: 302-306; discussion 306-307
23. Yonemura Y, Katayama K, Kamata T, Fushida S, Segawa M, Ooyama S, Miwa K, Miyazaki I. Surgical treatment of advanced gastric cancer with metastasis in para-aortic lymph node. Int Surg 1991; 76: 222-225
24. Baba M, Hokita S, Natsugoe S, Miyazono T, Shimada M, Nakano S, Takao S, Aikou T. Paraaortic lymphadenectomy in patients with advanced carcinoma of the upper-third of the stomach. Hepatogastroenterology 2000; 47: 893-896
25. Kunisaki C, Shimada H, Yamaoka H, Wakasugi J, Takahashi M, Akiyama H, Nomura M, Moriwaki Y. Significance of para-aortic lymph node dissection in advanced gastric cancer. Hepatogastroenterology 1999; 46: 2635-2642
26. Günther K, Horbach T, Merkel S, Meyer M, Schnell U, Klein P, Hohenberger W. D3 lymph node dissection in gastric cancer: evaluation of postoperative mortality and complications. Surg Today 2000; 30: 700-705
27. Zhan WH, Han FH, He YL, Li YM, Zheng ZQ, Peng JS, Cai SR, Ma JP. [Disciplinarian of lymph node metastasis and effect of paraaortic lymph nodes dissection on clinical outcomes in advanced gastric carcinoma] Zhonghua Weichang Waike Zazhi 2006; 9: 17-22
28. Wan Y, Pan Y, Liu Y, Wang Z, Ye J, Huang S. [Lymph node metastasis and the extent of lymph node dissection for gastric cancer: report of 326 cases] Zhonghua Waike Zazhi 2000; 38: 752-755
29. Bittorf BR, Günther F, Merkel S, Horbach T, Hohenberger W, Günther K. [D3 versus D2 dissection in stomach carcinoma. A case-control study of postoperative morbidity, survival and early oncologic outcome] Chirurg 2002; 73: 336-347
30. Yang SH, Zhang YC, Yang KH, Li YP, He XD, Tian JH, Lv TH, Hui YH, Sharma N. An evidence-based medicine review of lymphadenectomy extent for gastric cancer. Am J Surg 2009; 197: 246-251
31. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1998; 1: 10-24
32. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma. Tokyo: Kanehara, 1995
33. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated september 2008]. The Cochrane Collaboration, 2008. Available from: URL: http://www.cochrane-handbook.org
34. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999; 354: 1896-1900
35. http://www.cc-ims.net/RevMan/current.htm
36. Jiang BJ, Gao YF, Sun RX, Shen H, Lu M, Tu CL. Clinical study on the dissection of lymph nodes around abdominal aortic artery in advanced gastric cancer. Zhongguo Putong Waike Zazhi 2000; 9: 292-295
37. Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy - Japan Clinical Oncology Group study 9501. J Clin Oncol 2004; 22: 2767-2773
38. Kodera Y, Sasako M, Yamamoto S, Sano T, Nashimoto A, Kurita A. Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Br J Surg 2005; 92: 1103-1109
39. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008; 359: 453-462
40. Yonemura Y, Wu CC, Fukushima N, Honda I, Bandou E, Kawamura T, Kamata S, Yamamoto H, Kim BS, Matsuki N, Sawa T, Noh SH. Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons. Hepatogastroenterology 2006; 53: 389-394
41. Yonemura Y, Wu CC, Fukushima N, Honda I, Bandou E, Kawamura T, Kamata T, Kim BS, Matsuki N, Sawa T, Noh SH. Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol 2008; 13: 132-137
42. Kulig J, Popiela T, Kolodziejczyk P, Sierzega M, Szczepanik A. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg 2007; 193: 10-15
43. Maeta M, Yamashiro H, Saito H, Katano K, Kondo A, Tsujitani S, Ikeguchi M, Kaibara N. A prospective pilot study of extended (D3) and superextended para-aortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomy. Surgery 1999; 125: 325-331
44. Bostanci EB, Kayaalp C, Ozogul Y, Aydin C, Atalay F, Akoglu M. Comparison of complications after D2 and D3 dissection for gastric cancer. Eur J Surg Oncol 2004; 30: 20-25
45. Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono H, Nagahori Y, Hosoi H, Takahashi M, Kito F, Shimada H. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study. Ann Surg Oncol 2006; 13: 659-667
46. Hu JK, Yang K, Zhang B, Chen XZ, Chen ZX, Chen JP. D2 plus para-aortic lymphadenectomy versus standardized D2 lymphadenectomy in gastric cancer surgery. Surg Today 2009; 39: 207-213
47. Lee JH, Ryu KW, Lee JH, Park SR, Kim CG, Kook MC, Nam BH, Kim YW, Bae JM. Learning curve for total gastrectomy with D2 lymph node dissection: cumulative sum analysis for qualified surgery. Ann Surg Oncol 2006; 13: 1175-1181
48. Kunisaki C, Takahashi M, Fukushima T, Nagahori Y, Akiyama H, Makino H, Otsuka Y, Ono HA, Kosaka T, Takagawa R, Shimada H. The influence of stage migration on the comparison of surgical outcomes between D2 gastrectomy and D3 gastrectomy (para-aortic lymph node dissection): a multi-institutional retrospective study. Am J Surg 2008; 196: 358-363
49. Bunt AM, Hermans J, Smit VT, van de Velde CJ, Fleuren GJ, Bruijn JA. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 1995; 13: 19-25
50. Gunji Y, Suzuki T, Kobayashi S, Hori S, Hayashi H, Shimada H, Matsubara H, Nabeya Y, Ochiai T. Evaluation of D3/D4 lymph node dissection for patients with grossly N2 positive advanced gastric cancer. Hepatogastroenterology 2003; 50: 1178-1182
51. Kunisaki C, Shimada H, Yamaoka H, Takahashi M, Ookubo K, Akiyama H, Nomura M, Moriwaki Y. Indications for paraaortic lymph node dissection in gastric cancer patients with paraaortic lymph node involvement. Hepatogastroenterology 2000; 47: 586-589
52. Yu W, Choi GS, Chung HY. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br J Surg 2006; 93: 559-563